Archives of Medical Research
Volume 40, Issue 6 , Pages 499-502 , August 2009

Ethical Dilemmas and Great Expectations for Human Papilloma Virus Vaccination

  • Luis Benítez-Bribiesca

      Affiliations

    • Corresponding Author InformationAddress reprint requests to: Luis Benítez-Bribiesca, Oncology Research Unit, Oncology Hospital, Centro Medico Nacional Siglo XXI, Av. Cuauhtemoc 330, 4° piso, Bloque B, Unidad de Congresos, 06720 Mexico, D.F., Mexico; Phone and Fax: (+52) (55) 5761-1503)

Received 25 May 2009 ,Accepted 26 May 2009.

References 

  1. Adams M, Jasani B, Fiander A. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine. 2007;25:3007–3013
  2. Muñoz N. Review of the initial phase 3 clinical data for the quadrivalent human papilloma virus vaccine. In: 6th International Multidisciplinary Congress of the European Research Organization on Genital Infection and eoplasia (EUROGIN); 2006.
  3. Nichols JR, Stovall SH, Jacobs RF. Human papillomavirus infection: the role of vaccination in pediatric patients. Clin Pharmacol Ther. 2007;81:607–610
  4. Medical ethics. http://en.wikipedia.org/wki/Medical_ethics
  5. Colgrove J. The ethics and politics of compulsory HPV vaccination. N Engl J Med. 2006;355:2389–2391
  6. Chicken Pox vaccination. http://es.wikipedia.org/wiki/Viruela
  7. Opel DJ, Diekema DS, Marcuse EK. A critique of criteria for evaluating vaccines for inclusion in mandatory school immunization programs. Pediatrics. 2008;122:e504–e510
  8. Raffle AE. Challenges of implementing human papillomavirus (HPV) vaccination policy. BMJ. 2007;335:375–377
  9. Gostin LO, DeAngelis CD. Mandatory HPV vaccination: public health vs private wealth. JAMA. 2007;297:1921–1923
  10. Prasai S. Human papillomavirus vaccination: should it be mandatory?. J Nepal Med Assoc. 2008;47:167–171
  11. Harries J, Moodley J, Barone MA, et al. Preparing for HPV vaccination in South Africa: key challenges and opinions. Vaccine. 2009;27:38–44
  12. Balog JE. The moral justification for a compulsory human papillomavirus vaccination program. Am J Public Health. 2009;99:616–622
  13. Schwarts JL, Caplan AL, Faden RR, et al. Lessons from the failure of human papillomavirus vaccine state requirements. Clin Pharmacol Ther. 2007;82:760–763
  14. Zimmerman RK. Ethical analysis of HPV vaccine policy options. Vaccine. 2006;24:4812–4820
  15. Ault KA. Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review. Obstet Gynecol Surv. 2006;61(Suppl 1):S26–S31
  16. Blake SM, Ledsky R, Goodnew C, et al. Condom availability programs in Massachusetts high schools: relationships with condom use and sexual behavior. Am J Public Health. 2003;93:955–962
  17. Kann L, Kinchen SA, Williams BI, et al. Youth risk behavior surveillance—United States, 1999. MMWR Morb Mortal Surveill Summ. 2000;49(SS-5):1–96
  18. Centers for Disease Control and Prevention. National representative CDC study finds 1 in 4 teenage girls has a sexually transmitted disease (press release). March 11, 2008. Available at: http://www.edc.gov/STDConference/2008/media/release-11march2008.htm.
  19. Koutsky LA. Safety and efficacy on the HPV vaccine. In: HPV and Cancer. Future Prospects for Vaccination and Screening. E. Briefings New York Academy of Sciences; 2009;http://www.nyas.org/hpv-cancer
  20. Field RI, Caplan AL. A proposed ethical framework for vaccine mandates: competing values and the case of HPV. Kennedy Inst Ethics J. 2008;18:111–124
  21. Zimmerman RK. HPV vaccine and its recommendations, 2007. J Fam Pract. 2007;56(Suppl Vaccines):S1–S5C1
  22. HPV Vaccination program Mexico City. www.salud.df.gob.mx
  23. de Melo-Martin I. The promise of the human papillomavirus vaccine does not confer immunity against ethical reflection. Oncologist. 2006;11:393–396

PII: S0188-4409(09)00091-5

doi: 10.1016/j.arcmed.2009.05.009

Archives of Medical Research
Volume 40, Issue 6 , Pages 499-502 , August 2009

Article Tools